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A new classification approach was developed to improve
the noninvasive diagnosis of brain tumors. Within this
approach, information is extracted from magnetic reso-
nance imaging and spectroscopy data, from which the
relative location and distribution of selected tumor classes
in feature space can be calculated. This relative location
and distribution is used to select the best information
extraction procedure, to identify overlapping tumor classes,
and to calculate probabilities of class membership. These
probabilities are very important, since they provide in-
formation about the reliability of classification and might
provide information about the heterogeneity of the tissue.
Classification boundaries were calculated by setting thresh-
olds for each investigated tumor class, which enabled the
classification of new objects. Results on histopathologi-
cally determined tumors are excellent, demonstrated by
spatial maps showing a high probability for the correctly
identified tumor class and, moreover, low probabilities
for other tumor classes.
Magnetic resonance imaging (MRI) has become one of the
most important noninvasive aids in clinical diagnosis of brain
tumors, because it enables the radiologist to assess the anatomical
location and size of tumor tissue. Normally, multiple complemen-
tary images are recorded, as the acquisition of only one image
may not show the desired information. Another use of clinical
MR is to perform spatially resolved magnetic resonance spectros-
copy (MRS). In contrast to MRI, which has a high spatial
resolution, this method is performed at low spatial resolution, but
it involves the acquisition of metabolic information. The method
allows the use of several MR-sensitive nuclei, but often the proton
nucleus is used as it is the most sensitive one. Proton MRS at
multiple spatially resolved locations is referred to as proton
magnetic resonance spectroscopic imaging (1H-MRSI).1
When 1H-MRSI is applied to the human brain, the MR spectra
obtained on a clinical 1.5-T MR system commonly arise from
volumes (called voxels) of approximately 2-4 cm3. The spectra
contain information from important brain metabolites such as
glutamate, myoinositol, choline, creatine, N-acetyl aspartate (NAA),
lactate, and fatty acids.2 NAA is considered to be a neuronal
marker of which the levels are decreased in brain tumors. The
choline resonance arises from a group of compounds that are
involved in membrane synthesis and degradation, which is often
increased in tumors. The creatine signal reflects compounds
involved in energy metabolism and may be decreased in brain
tumors. Lactate is normally below detection limit, but it is often
increased in brain tumors. The function of myoinositol is largely
unknown, but its signal appears to be altered in some pathologies.
The signals from fatty acids are known to be increased in several
brain tumors, especially high grades, and are an indicator for
necrosis (cell death). Glutamate is an important neurotransmitter
in brain and elevated in oligodendrogliomas.3
The MRSI spectra could be used collectively with the anatomi-
cal MR images to spatially determine the type of tissue with a
high reliability. However, in a clinical setting, the increased
amount of information hampers the diagnosis, since radiologists
have to investigate multiple MR images and spectra. This is time-
consuming and often clinicians are not familiar with spectral
information. To deal with this problem, a project called INTER-
PRET (http://carbon.uab.es/INTERPRET) was funded by the
European commission. This project had the goal to develop new
methodologies to automatically type tumors in the human brain
with the use of MRS and MRI data. The resulting decision support
system enables clinicians to utilize MRS information for the
diagnosis of brain tumors. In this paper, a new approach is
presented to explore the information content of the combined MRI
and MRSI data, collected from patients with a brain tumor.
Imagelike maps can be generated that show the classification of
the tissue and the probability of classification in order to assist
the clinician in the interpretation of the data.
The development of statistical models (especially multivariate
ones) that are focused on the classification of brain tumors from
MRSI data is rather new. Some attempts have been made,4-7 but
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a dedicated multivariate determination of the location and distribu-
tion of classes in feature space has not been performed yet. Both
Preul4 and Szabo de Edelenyi6 focused on the quantitation of
metabolite regions from the spectroscopic data, followed by linear
discriminant analysis. Others have used pattern recognition8,9 on
single voxel MR spectra to classify10-13 or cluster14,15 multiple
tumor classes. The emphasis of data analysis is often put on
preprocessing,16,17 data reduction, and the search for appropriate
classification algorithms. However, a very important part of a
classification approach has not received much attention yet. This
deals with the assumption of multivariate normality, the identifica-
tion of class boundaries for each tumor class, the recognition of
overlap between classes, and the probability of classification.
Multivariate normality is important to consider if the classification
method assumes it, especially when probabilities of class member-
ship of a certain class are also to be given. The identification of
class boundaries is important since there are many different types
of brain tumors. The usually limited number of investigated tumor
classes in a classification procedure should therefore have strict
class boundaries. This leaves room for the noninvestigated classes
in feature space, which will (hopefully) be classified as ªunknownº
by the classifier. The probability of classification is important,
because it provides information on the reliability of classification.
Few papers deal with the combination of MRI and MRSI data
(Szabo de Edelenyi6 used information from the T2-weighted image,
combined with MRSI). If a patient with a brain tumor is
investigated, MR images with different contrasts are always
acquired. If a MRSI measurement is also performed, it would be
a waste to leave out the MRI information in the statistical models,
since the MR images are already available. It is possible to identify
morphologically different regions in the brain with MRI informa-
tion alone.18 If this information is combined with MRSI data, the
pathology of the regions might also be identified. Therefore, we
combined MRI and MRSI data in all our experiments.
The goal of this paper was threefold. First, to find an
appropriate feature selection technique for the MRSI data, while
preserving the distances and distribution of the classes in feature
space. We compared two techniques, simple quantitation of
spectral regions and principal component analysis. The second
goal was to find the isolated and overlapping classes of tissue types
in feature space and to create plots that showed their distribution.
These distribution plots can be used to generate spatial probability
maps, which show for each voxel the probability that it belongs
to a certain tissue class. The third goal was to develop a
classification model that uses thresholds that are set with use of
the distribution plots. These thresholds define class boundaries
for each class, enabling the classification of voxels to a specific
tissue type or as ªunknownº.
To address the above research issues, a training set was set
up using data from volunteers and patients with a brain tumor.
The construction of the distribution plots was performed with a
cross-validation method. The evaluation of the classifier was
performed with the leave-one-out method on the training set.
Furthermore, the resulting classification maps of the patients were
visually investigated. Most of the voxels within each classification
map of a patient were not selected within the training set. If the
classification map of a patient contained homogeneous regions
of healthy tissue, cerebrospinal fluid, and tumor tissue, then this
demonstrated robustness of the system to a large extent. Next to
this, two patients from which no data were selected for the training
set were validated.
EXPERIMENTAL SECTION
Data. Data from 18 patients with a brain tumor and 4
volunteers selected from the INTERPRET19 database were used.
Each patient case had passed strict quality control and validation
procedures, including consensus histopathological determination
of the tumor according to the rules of the World Health
Organization. For 2 of the 18 patients (I-1172, I-1281), a consensus
was not reached. Therefore, data from the tumor region of these
patients were not used in the training set.
For each subject, stacked MR images of cross sections of the
whole brain at four contrasts were acquired: T1- and T2-weighted
images, a proton density image, and a gadolinium-enhanced T1-
weighted image (256  256, FOV ) 200 mm, slice thickness 5
mm). In the T1- and T2-weighted images, the contrast reflects
differences in T1- and T2-relaxation times of the water protons in
the brain, respectively. In the proton density image, the distribu-
tion of protons produces the contrast. The contrast-enhanced
image (GD image) is obtained after intravenous administration
of Gd-DTPA solution. The paramagnetic Gd compound influences
the relaxation times of water protons and therefore regions are
highlighted that contain large blood vessels or where the blood-
brain barrier is disrupted due to proliferation of malignant tissue.
To ensure that image pixels from subsequent images originate
from the same spatial location, the images have to be coaligned.
The coalignment was performed by calculating the maximum
correlation between two images while shifting them left-right and
up-down. Coalignment is difficult but does not need to be perfect
in this method, because the high-resolution images are combined
with the low-resolution MRSI eventually.
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Besides the acquisition of images, 1H-MRSI data were also
acquired from each subject, both with and without water signal
suppression using a 2D STEAM 1H-MRSI sequence (16  16 
1024 matrix size, Tr ) 2000 or 2500 ms, TE ) 20 ms, slice
thickness 12.5 or 15 mm, FOV ) 200 mm, spectral width 1000
Hz, NS ) 2 (for the MRSI without water suppression, NS ) 1)).
When STEAM20 is applied, a box is selected from which the signal
is acquired by the application of three slice-selective radio
frequency pulses in the presence of x-, y-, and z-gradients. Only
the MRSI voxels within the STEAM box will contain signal, while
signals in voxels from outside the box are suppressed. The
STEAM box was positioned totally in the brain; therefore,
disturbing signals arising from the fat tissue surrounding the skull
were avoided. The location of the 1H-MRSI slice was selected and
aligned with the Gd image that showed the largest enhanced
tumor area. Thus, the MRSI slice (of at most 15-mm thickness)
was centered around a MRI slice of 5 mm. Since the MRI slices
above and below the selected MRI slice have a gap of 1.5 mm
with the selected slice, they are partially outside the view of the
MRSI slice. Therefore, only MR images from one slice location
have been used.
Proper preprocessing of the MRSI data is essential for
successful classification. All data were processed in the same
automatic way. In short: k-space data (16  16) was filtered by a
hanning filter of 50% using the LUISE software package (Siemens,
Erlangen, Germany), followed by zero filling to 32  32 and 2D
Fourier transformation to obtain time domain signals for each
voxel. Then, each voxel within the preselected STEAM box was
corrected for eddy current effects in the spectra using a method
that prevents the occasional occurrence of eddy current correction-
induced artifacts.21 This was followed by HLSVD22 filtering to
remove the residual water signal between 4.3 and 5.5 ppm. Next,
a simple but efficient baseline correction was applied, which
removed broad resonances. This was performed by exponential
filtering of the time domain signal of each voxel with a filter width
of 5 ms, followed by the subtraction of the residual from the
original time domain signal. To correct for first-order phase effects
(in principle the zero-order phase is removed by the eddy current
correction), the mean spectrum, which was calculated from all
spectra within the STEAM box of each patient's MRSI data set,
was manually optimized. This correction value was then applied
to each separate time domain signal of that data set. Finally, each
time domain signal was Fourier transformed and only the real
values of the complex spectrum was retained between 0.5 and
4.0 ppm (230 points). To normalize between patients, all spectra
of one data set were divided by the patients' mean water signal of
all voxels within the STEAM box, as calculated by singular value
decomposition23 from the unsuppressed MRSI data.
Next, the spatial resolution of the MR images and the MRSI
grid had to be readjusted, so that the two were in agreement.
Therefore, the resolution of the MR images was lowered to the
resolution of the MRSI grid by averaging the image pixels within
each spectroscopy voxel. The values within each low-resolution
image were scaled to the same range as the spectral data. After
preprocessing, each voxel within the grid was represented by a
spectrum of 230 variables (the region between 0.5 and 4.0 ppm)
and 1 variable from each MR image. This is schematically
represented in Figure 1a-c.
Setup of a Training Set. Based on the 16 patients for which
consensus about the histopathology was reached, four different
tumor classes were selected. The first three classes contained glial
tumors with different grades, grade II (6 patients), grade III (4
patients), and grade IV (5 patients). A fourth class consisted of a
patient (I-1283) with a meningioma (MNG). No classifier for this
class was calculated, because the size was too small, but it was
used to validate results of the classifier.
To create the training set, a selection of voxels from patients
who were in the same tumor class was made using the MR spectra
and the four MR images. The voxels were selected from regions
that clearly consisted of tissue belonging to the correct class.
Boundary voxels were not selected. Also, classes for healthy tissue
and cerebrospinal fluid (CSF) were created. The voxels for healthy
tissue were selected from the contralateral region of several
patients and from healthy volunteers. Data for the CSF were
selected from CSF voxels that were not in close contact with the
tumor region. The total number of voxels selected from a subject
was never more than 30%.
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Figure 1. Representation of preprocessing and data reduction. (a)
The images with the four contrasts (top, T1- and T2-weighted image;
bottom, proton density and Gd image) are aligned (the lower right
image has been shifted up) and the spectral grid within the STEAM
box has been superimposed on the images; (b) a spectrum after
preprocessing, obtained from the indicated voxel; (c) the resolution
of the images is reset to the MRSI resolution. Each voxel is
represented by four image variables now; (d) data reduction is
performed either with quantitation of important regions in the spectrum
(indicated with gray bands in Figure 1b) or with PCA of the spectra;
(e) the image variables from each voxel are combined with the
variables obtained from either data reduction technique. In this
example, the image variables are combined with the variables (scores)
obtained by PCA.
5354 Analytical Chemistry, Vol. 75, No. 20, October 15, 2003
Patient I-1172, for which no consensus was reached, was used
for the selection of training set data for healthy tissue and
cerebrospinal fluid. Data from patient I-1281 were not used for
the training set at all but were used as an independent test case
for evaluation, just like patient I-1283 (the MNG case). An overview
of the training set is given in Table 1.
Data Reduction Methods. After selection of the training set,
two different data reduction techniques were used to create two
separate training sets with reduced dimensionality, which were
validated for their robustness. The following techniques were
used:
(a) Quantitation of Important Spectral Regions. Quantita-
tion was performed in the following way: from the preprocessed
spectra, intensities of seven spectral ranges encompassing the
brain metabolites mentioned in the introduction were determined
by integrating the intensities within a window of 0.13 ppm at 3.75
(glutamate), 3.56 (myoinositol), 3.20 (choline), 3.02 (creatine), 2.02
(NAA), 1.33 (lactate), and 0.90 ppm (fatty acids). These seven
windows have been indicated with gray bands in Figure 1b. The
quantitation procedure is simple, robust, and easily automated. It
should be noted that the levels found with our procedure are only
an approximate indication of the true levels: only part of the peak
width is taken into account and negative values are acceptable in
case of a negative baseline. However, for classification purposes,
this appears to be adequate. The 7 spectroscopic variables (Figure
1d) and the 4 image variables (Figure 1c) were combined to create
a training set that contained 11 variables for each voxel.
(b) Principal Component Analysis of the Spectral Data.
The second data reduction technique used was principal compo-
nent analysis (PCA).24 PCA was performed on the spectra of the
training set, which consisted of 524 (MNG excluded) spectra with
230 variables each. PCA finds directions in the data that explain
most of the variance. These new axes are linear combinations of
the original ones and are orthogonal and ordered with respect to
the amount of explained variance. After PCA, the first seven
principal components, which explained 95.3% of the variance, were
retained. The number of principal components to use is normally
not straightforward. We used seven to make a comparison with
the seven variables obtained by the quantitation of important
spectral ranges as described above. By chance, the seven principal
components retained more than 95% of the variance, which is also
a limit used to choose the number of principal components. After
PCA, each voxel was described by seven variables (called scores,
Figure 1d) obtained from the MRSI modality and four from MRI
(Figure 1e).
Exploration of the Classes in Feature Space. To develop a
classifier that is able to classify a voxel as belonging to one of the
investigated classes or as ªunknownº or as ªundecidedº between
some tissue classes, we explored the distribution of each class in
feature space and compared it with the distribution of all other
classes. This was done for each class in both training sets created
by the two data reduction methods. First, the data representing
the voxels (objects) of the class under investigation were split,
separating at random 10% (A) from the rest (B). Then the
covariance matrix of B was calculated and used to calculate the
Mahalanobis distances (d) of all objects in A with respect to the
centroid of B. Also the Mahalanobis distances of all objects in
the other classes with respect to the centroid of B were calculated.
This procedure was repeated successively leaving the next 10%
of the class under investigation out, until all objects were left out
once. This procedure was repeated for all classes. Eventually, for
each tissue class, a plot was created that showed the percentage
of objects against the Mahalanobis distance from the classes
centroid for members of the class itself and for nonmembers. An
example of such a distribution plot is shown in Figure 2. The solid
line represents the percentage of healthy objects within a certain
Mahalanobis distance d from the centroid of the healthy class.
One hundred percent of the healthy objects in the training set
(created by the first data reduction method) are within a distance
of 6d from the healthy centroid. The dotted line represents the
percentage of all other objects in the training set (not belonging
to healthy) within a certain distance to the centroid of the healthy
class. Only a small percentage of nonhealthy objects are within a
(24) Vandeginste, B. G. M.; Massart, D. L.; Buydens, L. M. C.; De Jong, S.; Lewi,
P. J.; Smeyers-Verbeke, J. Handbook of Chemometrics and Qualimetrics: Part
B; Elsevier: New York, 1998; Chapter 33.
Figure 2. Distribution plot showing the distribution of “healthy”
objects (solid) and objects from other classes (dotted) with respect
to the centroid of the healthy class.
Table 1. Selected Patients, Volunteers, and Number of Voxels for Each Class in the Training Set
tumor class patient number (I-)a no. of voxels selected total
grade II 1227 1233 1260 1275 1278 1318 07 20 28 12 14 09 90
grade III 1212 1229 1230 1232 17 06 26 4 53
grade IV 1231 1234 1285 1286 1322 12 06 16 17 08 59
MNG 1283 15 15
healthy (volunteer) 1236 1237 1238 1239 29 31 25 37 122
healthy (patient) 1172 1212 1231 1285 1318 13 32 21 39 17 122
CSF 1172 1230 1231 1234 1275 1318 15 09 26 03 09 16 78
no consensus 1281 used as independent test case
total 539
a The patient numbers correspond with the INTERPRET 19 database.
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distance of 6d from the healthy centroid, and the healthy class is
therefore relatively isolated from the other classes.
Calculation of Probabilities of Class Membership. The
probability of class membership of a new object for a class was
calculated based on the true distribution of the class, which is
reflected by the distribution plot. The density at point xi of a
multivariate normal distribution (with p dimensions), characterized
by the mean í and covariance matrix ∑ is given by
In a nonnormalized way, the density is a direct estimator of
the probability that an object at point xi belongs to this multivariate
normal distribution. If the Mahalanobis distance of a new object
to a class centroid is known, the density and thus probability of
class membership can be calculated using this equation. In the
proposed approach, a slightly different method was used, based
on the ªtrueº distribution of each class shown in the distribution
plots.
To calculate the probability of class membership of a new
object to the healthy class (for example), first its Mahalanobis
distance to the class centroid was calculated. Using the experi-
mentally determined distribution plot in Figure 2, the percentage
of objects of the training set within this distance could be red.
For example, when an object has a distance of 3d from the centroid
of the healthy class, then 28% of the objects in the training set
was within this distance (arrow at 3d in Figure 2). Last, from a
theoretical determined curve, which showed the number of objects
a certain distance from the centroid of a multivariate normal
distribution against the density, the density could be red. If the
distribution plot in Figure 2 was precisely following the theoretical
distribution of a multivariate normal distribution, then the density
calculated by our approach would give the same result as the
density calculated by eq 1.
Classification of Voxels. To use the distribution plots as a
classifier, thresholds have to be set for each class. The value of
the threshold is dependent on the errors one accepts to take for
a specific tissue class. If one wants to classify 95% of the healthy
objects correctly (the R error is 5%), then the threshold has to be
set at the position shown in Figure 2 (dashed vertical line).
However, this means that 2% of the objects will be classified
incorrectly (â error) as healthy.
Classification of a new voxel is performed by projecting it in
the feature space. Then, its distance to the centroid of each class
is calculated. The voxel is only assigned to the closest class when
its distance to the centroid does not exceed the threshold. If the
distance exceeds the threshold, then it is classified as ªunknownº.
If overlapping classes are found, rules can be set up to classify
voxels as ªbelonging to either one of these classesº, as described
in the Discussion. If a voxel is classified as such, it may be
reclassified with another classifier, like a support vector machine,
especially constructed for the classification between two classes.25
Evaluation of the System. Evaluation of the system was
performed at four levels. First, the best data reduction method
was selected by comparison of the distribution plots constructed
with both methods. Second, the classifier was tested by a leave-
one-out procedure on the training set (n ) 524). Leave-one-out
testing is an accepted validation procedure when the number of
samples is low. The leave-one-out procedure was executed in the
following way. From the training set, the first sample was left out.
The remainder of the training set was used to calculate new
(independent to the left out sample) distribution plots. Then the
left-out sample was classified with use of the calculated distribution
plots. The classification thresholds were kept the same during
the leave-one-out procedure. This was repeated until all samples
were left out of the training set once.
Third, the classifier was evaluated using all the data from all
patients in the training set. This was performed by calculation of
the classification maps and probability of classification maps. Most
of the voxels of the patients were not used in the training set and
therefore could be used for validation. Since no ªtrueº tissue type
for these voxels were available, all maps were visually inspected
for obvious misclassifications. Regions that could be assigned
visually as healthy tissue, CSF, or the tumor by means of the MR
images had to be homogeneously classified as such in the
classification map. Last, the classification results of patient I-1283
(the meningioma) and patient I-1281 (for which no consensus was
reached) were also used for validation.
RESULTS AND DISCUSSION
Exploration of Classes in Feature Space. The distribution
plots can be used to compare data reduction techniques as
described above or the influence of other processing steps, e.g.,
normalization or scaling. In this study, only a comparison of data
reduction techniques was made. Each subplot in Figure 3 shows
the distribution plot of a tissue class. The solid black and dashed
gray visualize the percentage of objects of the class itself within
a certain Mahalanobis distance from its centroid. Theoretically,
the squared Mahalanobis distance should follow the Hotelling T2
statistics,26 which is plotted as the gray thick line for each class.
For all tissue classes, the plots follow T2 statistics, suggesting that
the multivariate data are normally distributed in space and that
using the Mahalanobis distance is justified for both approaches.
This is important, because the probabilities can only be calculated
if the data follow a normal distribution. The approach using
quantitated values seems to be better than the approach using
PCA, since objects not belonging to a class are always further
away from the class centroid for this method. This is especially
visible for the grade III and grade IV class (Figure 3d and e) in
which the black dotted line is lower than the gray dashed-dotted.
This suggests that the classes are more separated in the approach
using quantitated values and therefore this data set is used in the
remainder of the paper.
To investigate the distribution of all tissue classes that surround
a particular class, we plotted the Mahalanobis distance of all
objects (including MNG) within a class to the centroid of the
particular class under investigation (Figure 4). The surrounding
of the healthy class is relatively empty. At a Mahalanobis distance
of 6d from its centroid, objects from the cerebrospinal fluid class
arise. Objects from other classes, however, are almost absent until
(25) Lukas, L.; Devos, A.; Suykens, J. A. K.; Vanhamme, L.; Van Huffel, S.; Tate,
A. R.; MajoÂs, C.; AruÂ s, C. ESANN'2002 Proceedings: European Symposium
on Artificial Neural Networks, 2002; pp 131-136.
(26) Candolfi, A.; De Maesschalck, R.; Jouan-Rimbaud, D.; Hailey, P. A.; Massart,
D. L. J. Pharm. Biomed. Anal. 1999, 21, 115-132.
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a distance of 8d. The CSF class has some overlap with objects
from the healthy class at 6d, but no overlap with other classes at
all (Figure. 4b). This suggests that healthy tissue and CSF are
dense clouds in feature space, which have some overlap with each
other but not with malignant tissue. Therefore, one may expect
some error between these classes but low error between healthy/
CSF and any of the other classes. This is in agreement with
findings of other researchers,6,12,13 who found that healthy tissue
can be classified with a high reliability. This can be explained by
the stringent concentrations of metabolites in the human brain
for healthy tissue. The overlap of CSF with healthy is likely due
to partial volume effects.
The grade II class overlaps with the grade III class, but not
with grade IV or MNG (Figure 4c). It is therefore very well
possible to separate grade II from grade IV and MNG objects,
but separation of grade II from grade III will be hard. The same
can be concluded from Figure 4d, which describes the grade III
distribution. The grade IV class is separated from all other classes,
suggesting that this class can be classified with a high reliability.
As pointed out, we included the MNG class in Figure 4a-d,
Figure 3. Distribution plots for each class using both data reduction
approaches. (a) The distribution of the healthy class is plotted in solid
black for the quantitation of spectral ranges method and in dashed
gray for the PCA method. Both distributions follow Hotelling T2
statistics, which is plotted as a thick gray band. Also, the percentage
of nonhealthy training samples within a certain Mahalanobis distance
from the centroid of the healthy class is plotted for each data reduction
approach. The dotted black corresponds with the quantitation of
spectral ranges method and the dashed-dotted gray for the PCA
method. (b-e) The same as (a), but now for the CSF, grade II, grade
III, and grade IV class, respectively.
Figure 4. Distribution plots of each class and its surrounding classes
using the quantitation of spectral ranges method for data reduction.
In each subplot, the solid black line represent the percentage of
healthy objects within a certain distance to the centroid of the class
under investigation. The dashed-dotted black line represents CSF,
the dashed-black line, grade II. The solid gray, dashed-dotted gray,
and dashed gray respectively represent grade III, grade IV, and MNG.
The vertical dotted lines indicate the thresholds used for the clas-
sification.
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because it gives relevant information about the location of MNG
in feature space.
The distribution plots are very import for the interpretation of
the classes in feature space. If a new class is added, one can
directly see whether this new class has a significant overlap with
any of the other classes. Assume that a new class A is overlapping
with class B. If a new object is classified to class A, but the
probabilities for both classes A and B are high, then the reliability
of classification is low. The object might also be a member of
class B. If classes A and B are from totally different tumor types,
which normally do not occur together in the brain, then the
classification is A, with a low reliability. On basis of other
information, the clinician might decide that the ªtrueº classification
is A. It can also be that the classes A and B are from the same
tumor type, but with a different grade. This is, for example, the
case for the grade II and grade III classes of glial tumors described
in this paper. A mixture of these two tumor types can occur in
the brain. If the probability for classes A and B is high now, and
the two classes are from different grades, then the tissue could
also be a mixture of both classes and thus heterogeneous. The
expert user has to keep this in mind during use of the classifier.
As explained in the Experimental Section, probability maps
for a new patient can be constructed using the distribution plots
of Figure 4. Maps are presented from patients with a histologically
proven grade III (Figure 5a and d), a grade II (Figure 5b), and a
grade IV (Figure 5c) tumor. The darker a voxel in a map, the
higher the probability that the underlying tissue belongs to the
class represented by the map. The images give a very consistent
indication of the different tissues in the brain, indicating robust-
ness of the system. Remember that only several voxels of each
patient have been used in the training set. The number of voxels
used in the training set and the number of total voxels is specified
Figure 5. Overview of probability maps of four patients. For each patient, a MR image is shown on the left with a contrast that clearly identifies
the tumorous region. The MR images are zoomed, and only the MRSI grid within the STEAM box is depicted. Next to the MR image, the
probability maps for the five classes are shown. (a) Patient I-1229 (6/156), which has a grade III tumor. After the patient label, the number of
voxels used in the training set and the total number of voxels for this patient are depicted between brackets. The MR image is T2-weighted. (b)
Patient I-1275 (21/180), which has a grade II tumor. The MR image is T2-weighted. (c) Patient I-1285 (55/168), which has a grade IV tumor. The
MR image is proton density-weighted. (d) Patient I-1212 (49/171), which has a grade III tumor. The MR image is T2-weighted.
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in the figure caption for each patient. For the interpretation of
the probability maps, it is important to compare them region wise,
because the probabilities are relative. When a region in the
probability map of grade II is dark, while it is bright on the other
maps, then the estimation of class membership is high. When
the region is dark in more than one map, then the estimation of
class membership is lower. As explained, the probabilities of
classification might also be important for the assessment of tumor
heterogeneity. When the probability in a region is high for only
one tissue type, then the tissue will be, in general, homogeneous.
If the probability in a region is high for two tissue types, then the
region might be a mixture of these tissues and, therefore,
heterogeneous. However, this can only be the case if the mixture
of these two tissues is possible from a clinical point of view.
Otherwise, on can only say that the reliability of classification is
low. In addition to other classification procedures that try to assess
tissue heterogeneity with a spatially resolved classifications
algorithm4,6 or the construction of metabolic maps,27,28 the use of
statistically calculated probabilities could be an important asset
to the mapping of tumor heterogeneity.
Classification of Voxels. For the classification, we created
classification rules based upon the results presented in Figure 4.
The healthy and the CSF classes are isolated in feature space,
having some overlap with each other. To minimize the R error,
we have set the threshold to 6d for these classes as shown by the
vertical dotted line in Figure 4a and b. The same can be concluded
for the grade IV class, with a threshold of 5.5d. This leaves some
R error for grade IV but minimizes the chance that a healthy or
CSF object will be falsely classified as grade IV. Because of the
overlap of the grade II and grade III classes, we defined different
rules for these classes. When an object is very close (e2.5d) to
the centroid of one of these classes it is appointed to it (threshold
at 2.5d), but when the distance is between 2.5 and 5.5d, other
rules were applied. (a) If the object was closest to the grade II
class and the distance of the object to the grade III class was 1.3
times larger than to the grade II class, then it was assigned to
the grade II class. This rule can be applied because all other
classes are far away from the grade II class. (b) If the distance of
the object to the grade III class is smaller than 1.3 times the
distance to the grade II class, then it is a grade II or a grade III
member and thus ªundecidedº between these two classes. We
applied identical rules when the object was closest to the grade
III class. The value of 1.3 was found by repeating the classification
for different values and assessing the number of objects that were
classified as ªundecidedº.
Classification using leave one out is excellent for the healthy
(100% correct), CSF (97% correct, the 3% being misclassified as
healthy), and grade IV (100% correct) classes. Classification results
for GII and GIII were promising. A total of 83% of the GII objects
were classified correctly and 88% of the GIII class. However, the
largest part of the misclassified objects in the GII and GIII classes
were classified as ªundecidedº (12% for the GII and 4% for the
GIII class), which is to be expected since these classes are
overlapping. A total of 2% of the GII objects were misclassified as
GIII and 3% of the GIII as GII, respectively. Last, some objects of
the GII and GIII classes were classified as ªunknownº (3 and 5%).
All MNG objects were classified as ªunknownº, which is correct
as we did not build the classifier to be able to take MNG into
account.
To compare the method with a commonly used algorithm,4,6
we performed linear discriminant analysis (LDA)24 with use of
leave one out. In general, the number of correctly classified objects
for each class using LDA was in correspondence with the
presented method, but when LDA was used, the misclassified
objects were often assigned to classes not expected. Objects from
the healthy and CSF classes were wrongly assigned to grade II
(respectively, 0.5 and 1%). A total of 5% of the GII was misclassified
as GIII, and 11% of the GIII as GII; 1.5% of the GIII was
misclassified as GIV.
The results of LDA may be caused by the fact that LDA can
only be used if the classes under investigation have equal
covariance in size and shape. In our data set, this was not the
case. The healthy and CSF classes are much more condensed
than the tumor classes. This will probably always be the case,
because the highly structured brain will give rise to spectra with
low variance, while heterogeneous tumor tissue with a broader
range of morphologic and metabolic abnormalities will give rise
to MR images and spectra with high variance.
In Figure 6, the classification results of the patients presented
in Figure 5 are shown, together with two other patients. The
patient in Figure 6e (I-1318) has a grade II tumor; the pathology
of the tumor of the patient in Figure 6f (I-1281) is unclear, since
the pathologists who validated the tumor disagreed between grade
II and grade III. Therefore, this patient was not used during
training of the classifier but was used as a test case. Also, all other
patients have been evaluated, showing results similar to those of
the patients presented.
Although only a small part of the voxels from patients a-e
are used for training the classifier, the results look very good. As
an example we have indicated the voxels used in the training set
for the patient in Figure 6a with white circles. Only 6 of the 156
voxels of this patient were used for training! Important consider-
ations for the evaluation are as follows: (a) voxels that are
identically classified tend to be spatially grouped, (b) the spatial
distribution of classification is in agreement with morphological
information from the MR images, (c) in most patients, only one
tumor type is assigned, and this assignment is always in agree-
ment with the pathology of the patient, (d) most grade III patients
also show grade II voxels, which can be expected, because the
pathologist types the patient with respect to the most malignant
tissue present. However, grade II patients do not show grade III
classified voxels. This is important since otherwise a clinician
could assume grade III tumor based on one or two falsely
classified grade II voxels. In Figure 6d and e, voxels have been
misclassified as grade IV. In the case of (d), the misclassification
could have occurred because it is a corner voxel. These voxels
normally have a low signal, since the boundary setup by the
STEAM box is never perfect.
The classification result of the patient in Figure 6f is fairly good
for the healthy and CSF tissue. There are misclassified voxels in
the border region of healthy and CSF that might be caused by
partial volume. In the tumor area, none of the voxels have been
classified as grade III, suggesting this is a grade II tumor, but
(27) Segebarth, C.; BaleÂriaux, D.; Luyten, P. R.; den Hollander, J. A. Magn. Reson.
Med. 1990, 13, 62-76.
(28) Furuya, S.; Naruse, S.; Ide, M.; Morishita, H.; Kizu, O.; Ueda, S.; Maeda, T.
NMR. Biomed. 1997, 10, 25-30.
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the probability of grade II shown on the probability maps (inset)
is not very high for most voxels. The disagreement between the
two radiologists of this patients pathology is therefore reflected
in the results of the classifier and probability maps.
Last, the patient with the meningioma tumor was evaluated
(classification result not shown). Again, no voxels from this patient
were selected for the training set. The classification map shows
normal tissue in regions outside the tumor. The area of the tumor
is classified as ªunknownº, which is correct as the classifier was
not built to be able to classify meningiomas.
CONCLUSIONS
A new classification approach was developed that enables the
classification and probability of classification of brain tumors on
the basis of magnetic resonance spectroscopy and imaging data.
The model can be used to determine the best preprocessing or
data reduction technique in feature space and to recognize overlap
of classes. The results of classification, including probabilities, are
presented as images to facilitate the interpretation in a clinical
environment.
Figure 6. Classification result of six patients. The classification is projected over a MR image with a contrast that clearly identifies the tumorous
region. (a) Patient I-1229, pathology: grade III, T2-weighted image. (b) Patient I-1275, pathology: grade II, T2-weighted image. (c) Patient
I-1285, pathology: grade IV, proton density-weighted image. (d) Patient I-1212, pathology: grade III, T2-weighted image. (e) Patient I-1318
(42/195), pathology: grade II, T2-weighted image. (f) Patient I-1281, no consensus of the patient’s pathology was reached. The radiologists
differed between grades II and III. None of the voxels of this patient have been used for training. The inset shows a section (indicated by the
black square on the classification map) of three probability maps of healthy, grade II, and grade III. Note that a voxel classified as “undecided”
can be either a grade II or a grade III.
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Comparison of PCA and quantification of spectral ranges to
reduce the number of variables in feature space gave similar
results. The last method was favored, because it was slightly better
and because the variables retain a meaningful property. However,
PCA is much easier to perform, is not subjective to quantification
error, and is therefore a good competitor.
Exploration of the classes in feature space as presented is a
powerful method to compare class distances, distributions, and
class boundaries. It can be used to identify tumor classes that
are not separable, because they overlap in feature space. The
overlap between the grade II and III tumor classes can be
understood if the method to identify the pathology is considered.
When only a small part of the tumorous cells are found to be
grade III, the pathology of the patient will be grade III, whereas
the spectral features may arise from a bulk of grade II tissue. It
is, therefore, never possible to separate these two classes perfectly.
The classification thresholds of the model thus have to be set to
minimize the number of voxels falsely classified as grade III in
patients with a grade II tumor.
The calculation of probabilities of classification from MRI and
MRS data is relatively new. The probability maps are very
important for interpretation of the classification image. It provides
information of the reliability of classification for each voxel, shows
whether voxels have a high probability for a class they were not
classified to, and can be used as a direct identifier of tissue
heterogeneity in certain cases.
Unfortunately, as in any classifier, the classification approach
is limited to classification of the classes in the training set. There
are many different types of tumor, so an addition of classes to
the training set in future would be highly desirable. Then it would
also appear whether totally different tumor classes show overlap
in feature space. However, the presented approach recognizes
ªunknownº tumor classes, so at the moment it is a valuable
method to differentiate between glial tumors and other tumors.
Furthermore, it provides the grade and probability of class
membership for glial tumors, which are important parameters in
tumor diagnosis.
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